Skin incision device for catheter placement system

Abstract

A skin lancing device (210) for enlarging an insertion site for catheter placement is slidably coupled to a needle (120) and has one or more blades (230) mounted to a frame (214). Displacing the skin lancing device distally along the needle causes the blades to incise the skin and enlarge the insertion site. A shield (214) of the skin lancing device transitions between a safety configuration that stores the blade and a use configuration that exposes the blade, with the shield biased toward the safety configuration. A latch (217) secures the shield in the safety configuration and an actuator (218) releases the latch. A sheath (216) of the skin lancing device includes a needle slidably disposed within a lumen of the sheath and a sharp tip of the blade embedded within the wall of the sheath.

Description

[Technical field]

[0001] The present invention relates to a skin lancing device for a catheter placement system. [Background technology]

[0002] Central venous catheters ("CVCs") are typically introduced into patients and advanced along the vascular system by the Seldinger technique. The Seldinger technique involves many steps and medical instruments (e.g., needles, scalpels, guidewires, introducer sheaths, dilators, CVCs, etc.). Although the Seldinger technique is effective, it is time-consuming due to the large number of steps and cumbersome handling of medical instruments, both of which may increase the patient's risk of trauma and infection. Due to the large number of medical instruments exchanged during the Seldinger technique, the potential for contact contamination is relatively high. Therefore, advanced catheter placement systems have been developed to reduce the number of steps and medical instruments required to place a catheter such as a CVC in a patient.

[0003] Some of these advanced catheter placement systems use a needle to access the vasculature and a guidewire to stabilize the access site. Once the guidewire is in place, the skin and fascia at the insertion site may be incised or scored with a scalpel to facilitate catheter insertion. If the skin incision is not properly made, a skin nicking device may form that may impede catheter insertion through the skin and into the vessel. A skin nicking device may be used to create a reproducible incision depth and reduce the likelihood of leaving a skin bridge around the insertion site. Disclosed herein are advanced catheter placement systems and associated methods for incising the skin at the insertion site to eliminate skin bridging that would impede catheter insertion into the vasculature. Summary of the Invention

[0004] Disclosed herein, according to some embodiments, is a catheter placement device including a needle configured to establish an insertion site for a vascular catheter, the needle defining a needle lumen extending between a distal end and a needle hub at a proximal end. The catheter placement device further includes a skin incision device slidably coupled to the needle, the skin incision device including a blade configured to incise skin adjacent the insertion site to enlarge the insertion site, and a shield, the shield being transitionable between (i) a safety configuration in which the blade is retracted by the shield and (ii) a use configuration in which the blade is exposed to incise the skin.

[0005] In some embodiments, the skin lancing device includes a frame coupled to the blade and the shield, hi some embodiments, the frame is coupled to the needle hub such that in the absence of a separation force applied to the skin lancing device by the clinician, the frame is held in position by the needle hub.

[0006] In some embodiments, the shield is rotatably coupled to the frame such that the shield is rotatable between the safety configuration and the use configuration. In some embodiments, the shield is slidably coupled to the frame such that the shield is displaceable between the safety configuration and the use configuration. In some embodiments, the shield is longitudinally displaceable between a distal position corresponding to the safety configuration and a proximal position corresponding to the use configuration. In some embodiments, the shield is biased toward the safety configuration.

[0007] In some embodiments, the skin incision device further includes a latch operably coupled between the shield and the frame, the latch configured to prevent the shield from transitioning from the safe configuration to the use configuration in the absence of intentional action by the clinician. In some embodiments, the latch includes an actuator configured to release the latch as a result of the intentional action, thereby allowing the shield to transition from the safe configuration to the use configuration.

[0008] In some embodiments, the blade is fixedly attached to the frame such that the blade extends distally from the frame. In some embodiments, the blade includes a sharp edge and a dull edge, the sharp edge facing away from the dull edge and the sharp edge disposed at an angle relative to the dull edge. In some embodiments, the sharp edge and the dull edge converge to define a sharp tip at the distal end of the blade.

[0009] In some embodiments, the blade is fixedly mounted to the frame such that (i) the blunt edge faces toward the needle, (ii) the sharp edge faces radially away from the needle, and (iii) the sharp tip is positioned immediately adjacent to the needle.

[0010] In some embodiments, the skin incision device includes a tubular sheath coupled to the frame distally away from the frame along with a needle, the needle being disposed within the lumen of the tubular sheath. In some embodiments, the sharp tip is disposed radially inward of an outer diameter surface of the tubular sheath. In some embodiments, the sharp tip is embedded in the wall of the tubular sheath.

[0011] In some embodiments, the skin incision device includes a second blade, the second blade fixedly coupled to the frame such that the second blade is disposed opposite the aforementioned blade, hi some embodiments, the shield is configured to retract the second blade in the safety configuration and expose the second blade in the use configuration.

[0012] Also disclosed herein is a method of placing a catheter in a patient's vascular system, according to some embodiments, the method including: (i) accessing a blood vessel with a needle to define an insertion site for the catheter; (ii) transitioning a shield of a skin incision device coupled to the needle from a safety configuration to a use configuration to expose a blade of the skin incision device; (iii) sliding the skin incision device distally along the needle toward the insertion site; (iv) incising the skin with the blade to enlarge the insertion site; and (v) placing the catheter in the vascular system.

[0013] In some embodiments of the method, lancing the skin includes sliding a skin lancing device distally along the needle such that a blade extends to the insertion site. In some embodiments, the method further includes decoupling the frame of the skin incision device from the needle hub of the needle.

[0014] In some embodiments, the method further includes releasing a latch operably coupled between the shield and the frame to allow the shield to transition from the secure configuration to the use configuration.

[0015] In some embodiments, the method further includes transitioning the shield from the use configuration to a safety configuration to retract the blade. In some embodiments of the method, transitioning the shield includes rotating the shield.

[0016] In some embodiments of the method, transitioning the shield from the safety configuration to the use configuration includes slidably displacing the shield from a distal position to a proximal position. In some embodiments of the method, transitioning the shield from the safety configuration to the use configuration includes contacting the skin with the shield and displacing the skin incision device further distally along the needle such that the skin exerts a proximal force on the shield to displace the shield from the distal position toward the proximal position.

[0017] These and other features of the concepts provided herein will become more apparent to those of ordinary skill in the art in view of the accompanying drawings and following description, which disclose in more detail certain embodiments of such concepts.

[0018] A more particular description of the present disclosure will be provided by reference to specific embodiments thereof that are illustrated in the accompanying drawings. These drawings depict only typical embodiments of the invention and therefore should not be considered as limiting its scope. Exemplary embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings. [Brief description of the drawings]

[0019] [Figure 1A] FIG. 1 shows a perspective view of a catheter placement system in a deployed configuration according to an embodiment disclosed herein. [Figure 1B] FIG. 1 illustrates a top view of a catheter placement system in a folded configuration ready for use, according to an embodiment disclosed herein. [Figure 1C] FIG. 1 illustrates a perspective view of a catheter placement system in a folded configuration according to an embodiment disclosed herein. [Diagram 2] FIG. 1 shows a side view of a catheter of a catheter placement system in a deployed configuration according to an embodiment disclosed herein. [Figure 3A] 3 shows an enlarged detailed view of a distal portion of the catheter of FIG. 2 according to an embodiment disclosed herein. [Figure 3B] 3B shows a cross-sectional view of the catheter of FIG. 3A according to an embodiment disclosed herein. [Figure 3C] 3B shows a cross-sectional view of the catheter of FIG. 3A according to an embodiment disclosed herein. [Figure 4] 1 shows a longitudinal cross-sectional view of a distal portion of a catheter placement system according to an embodiment disclosed herein. [Figure 5A] 1 illustrates an exemplary method of use of a catheter placement system according to embodiments disclosed herein. [Figure 5B] 1 illustrates an exemplary method of use of a catheter placement system according to embodiments disclosed herein. [Figure 5C] 1 illustrates an exemplary method of use of a catheter placement system according to embodiments disclosed herein. [Figure 5D] 1 illustrates an exemplary method of use of a catheter placement system according to embodiments disclosed herein. [Figure 5E] 1 illustrates an exemplary method of use of a catheter placement system according to embodiments disclosed herein. [Figure 6A] 1 illustrates a cross-sectional view of a skin incision device in a safety configuration, according to some embodiments. [Figure 6B] 1 illustrates a cross-sectional view of a skin incision device in a use configuration, according to some embodiments. [Figure 7A] 1 shows a cross-sectional view of a skin lancing device including a safety mechanism, according to some embodiments. [Figure 7B] 1 shows a cross-sectional view of a skin lancing device including a safety mechanism, according to some embodiments. [Figure 8A] 1 illustrates a top view of a skin incision device, according to some embodiments. [Figure 8B] 1 illustrates a top view of a skin incision device, according to some embodiments. [Figure 9] 1 shows a flowchart of an exemplary method of placing a catheter using a catheter placement system, according to some embodiments. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] Before disclosing some specific embodiments in more detail, it should be understood that the specific embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that the specific embodiments disclosed herein may have features that can be easily separated from the specific embodiment and, optionally, combined with or substituted for features of any of the other embodiments disclosed herein.

[0021] With regard to the terms used herein, it should also be understood that these terms are intended to describe some particular embodiments, and that these terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps within a group of features or steps, and do not provide serial or numerical limitations. For example, the "first," "second," and "third" features or steps do not necessarily have to appear in that order, and a particular embodiment including such features or steps is not necessarily limited to three features or steps. Designations such as "left," "right," "up," "down," "front," "rear," etc. are for convenience and do not imply, for example, a particular fixed position, direction, orientation, etc. Instead, such designations are used to reflect, for example, a relative position, orientation, or direction. The singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0022] For example, with respect to the "proximal," "proximal portion," or "proximal end portion" of a catheter disclosed herein, includes the portion of the catheter that is intended to be near the clinician when the catheter is used on a patient. Similarly, for example, the "proximal length" of a catheter includes the length of the catheter that is intended to be near the clinician when the catheter is used on a patient. For example, the "proximal end" of a catheter includes the end of the catheter that is intended to be near the clinician when the catheter is used on a patient. The proximal portion, proximal end portion, or proximal length of a catheter can include the proximal end of the catheter. However, the proximal portion, proximal end portion, or proximal length of a catheter need not include the proximal end of the catheter. That is, unless the context suggests otherwise, the proximal portion, proximal end portion, or proximal length of a catheter is not the terminal portion or terminal length of the catheter.

[0023] For example, with respect to the "distal," "distal portion," or "distal end portion" of a catheter disclosed herein, includes the portion of the catheter that is intended to be near or within the patient when the catheter is used with the patient. Similarly, for example, the "distal length" of a catheter includes the length of the catheter that is intended to be near or within the patient when the catheter is used with the patient. For example, the "distal end" of a catheter includes the end of the catheter that is intended to be near or within the patient when the catheter is used with the patient. The distal portion, distal end portion, or distal length of a catheter can include the distal end of the catheter. However, the distal portion, distal end portion, or distal length of a catheter need not include the distal end of the catheter. That is, unless the context suggests otherwise, the distal portion, distal end portion, or distal length of a catheter is not the terminal portion or terminal length of the catheter.

[0024] Any method disclosed herein includes one or more steps or actions for carrying out the described method. Method steps and / or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of an embodiment, the order and / or use of specific steps and / or actions may be changed. Furthermore, only some of the subroutines or methods described herein may be separate methods within the scope of the present disclosure. In other words, some methods may include only some of the steps described in a more detailed method. In addition, all embodiments disclosed herein are combinable and / or interchangeable unless otherwise stated, or such combination or interchange would be contrary to the described enablement of any embodiment.

[0025] The phrases "connected to," "coupled to," and "in communication with" refer to any form of interaction between two or more entities, including, but not limited to, mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interactions. Two components may be coupled to one another even if they are not in direct contact with one another. For example, two components may be coupled to one another through an intermediate component.

[0026] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. 1A-1C illustrate an exemplary advanced catheter placement system ("system") 100, which generally includes a needle 120, a guidewire 130, a syringe system 140, a catheter 150, and a needle housing ("housing") 170. FIG. 1A illustrates the system 100 in a deployed configuration for ease of illustration. FIG. 1B illustrates a top view of the system 100 in a folded configuration ready for use. FIG. 1C illustrates a perspective view of the system 100 in a folded configuration. In one embodiment, the catheter placement system 100 may be a Rapidly Insertable Central Catheter (RICC) placement system 100 configured to place a RICC 150. However, alternative catheter placement systems configured to place other types of catheters are also contemplated. Exemplary catheters 150 may also include peripheral intravenous (PIV) catheters, peripherally inserted central catheters (PICC), central venous catheters (CVC), midline catheters, dialysis catheters, single lumen catheters, multi-lumen catheters, and the like.

[0027] In one embodiment, the catheter 150 may generally include a catheter body 152 supported at a proximal end by a catheter hub ("hub") 160. The hub 160 may include one or more extension legs 162 extending proximally from the hub 160. Each extension leg of the one or more extension legs 162 may be in communication with a lumen of the catheter body 152. The catheter body 152 may include a distally disposed first portion 154, a proximally disposed second portion 156, and a transition portion 158 disposed therebetween. The first portion 154 may define a single lumen and may have a first outer diameter, and the second portion 156 may define two or more lumens and may have a second diameter greater than the first diameter. The transition portion 158 disposed between the first portion 154 and the second portion 156 may define a tapered shape extending from a first diameter of the first portion to a second diameter of the second portion. The guidewire 130 may extend through the lumen of the catheter 150 from the proximal end of the extension leg 162 to the distal tip of the first portion 154 .

[0028] FIG. 2 shows further details of an exemplary catheter 150 of the system 100. As described herein, different portions of the catheter 150 are required to perform different functions and therefore are required to exhibit different mechanical properties. For example, the first portion 154 and the transition portion 158 can include a material with stiffer mechanical properties or harder durometer compared to the second portion 156. As such, the first portion 154 and the transition portion 158 can withstand greater axial forces without kinking or collapsing as the portions are biased distally to form and expand the insertion site. The second portion 156 can be formed of a material with a softer durometer or more pliable material to allow the second portion 156 to easily pass through tortuous vascular pathways.

[0029] 3A-3C show further details of a distal portion of catheter 150, including first portion 154, second portion 156, and transition portion 158. In one embodiment, second portion 156 can include a proximal lumen 114A terminating at a proximal lumen opening 116A and an intermediate lumen 114B terminating at an intermediate lumen opening 116B. Each of proximal lumen opening 116A and intermediate lumen opening 116B can extend through a sidewall of second portion 156. Each of proximal lumen opening 116A and intermediate lumen opening 116B can be disposed proximal to transition portion 158. Proximal lumen opening 116A can be disposed proximal to intermediate lumen opening 116B.

[0030] FIG. 3B illustrates a cross-sectional view of the catheter body 152 at position "A" of FIG. 3A. As shown, the first portion 154 can define a single lumen and a relatively small outer diameter. In one embodiment, a proximal portion of the first portion 154 can be contained within a distal portion of the transition portion 158. The distal lumen 114C of the catheter 150 can extend to the distal tip 118 of the catheter 150 and can communicate with the distal lumen opening 116C. FIG. 3C is a cross-sectional view of the second portion 156 at position "B" of FIG. 3A, showing the proximal lumen 114A, the intermediate lumen 114B, and the distal lumen 114C.

[0031] FIG. 4 illustrates a longitudinal cross-sectional view of a distal portion of the catheter placement system 100 including the needle 120, the guidewire 130, a distal portion of the syringe system 140, and a needle housing ("housing") 170 including a needle splitter system 180, as described in more detail herein. In one embodiment, the proximal end of the needle 120 may be supported by a needle hub coupled to and supported by the distal end of the syringe system 140. The syringe system 140 may be in communication with the needle lumen 122. The syringe system 140 may be configured to form a vacuum therein to draw a flow of fluid proximally through the needle lumen 122. In one embodiment, the needle 120 may include a guidewire aperture 124 disposed in a wall of the needle 120 and in communication with the needle lumen 122. A distal portion of the guidewire 130 may extend into the needle lumen 122 through the guidewire aperture 124. In one embodiment, the distal tip 138 of the guidewire 130 can be positioned proximate to the distal tip 128 of the needle 120. Thus, once the needle 120 reaches the vasculature, the distal tip 138 of the guidewire 130 can be positioned within the vasculature, allowing rapid placement of the catheter 150.

[0032] In one embodiment, the catheter placement system 100 can include a housing 170. The housing 170 can include a housing lumen 172 extending between a proximal end 176 and a distal end 178 of the housing 170. The housing 170 can further include a guidewire lumen 174 in communication with and extending obliquely from the housing lumen 172. A portion of the needle 120 can be slidably engaged with the housing lumen 172. Additionally, the proximal end 176 of the housing can be releasably engaged with one or both of the needle hub and a distal portion of the syringe system 140. When the housing 170 is engaged with the syringe system 140, the guidewire opening 124 of the needle 120 can be aligned with the guidewire lumen 174 of the housing 170. Thus, guidewire 130 can extend through guidewire lumen 174 of housing 170, through guidewire opening 124 of needle 120, and into needle lumen 122.

[0033] 5A-5E illustrate an exemplary method of placing a catheter 150 using the catheter placement system 100. As shown in FIG. 5A, the needle 120 can penetrate the patient's superficial tissue 90 and access the vasculature 80 to create an insertion site. As shown in FIG. 5B, a syringe system 140 or similar device can create a vacuum and draw fluid flow proximally through the needle lumen 122. The user can observe color or pulsatile flow to confirm correct vascular access. If incorrect vascular access is confirmed, the needle 120 can be withdrawn and the insertion site closed. As shown in FIG. 5C, once correct vascular access is confirmed, a guidewire 130 can then be advanced through the needle lumen 122 and into the vasculature 80 to maintain patency of the insertion site.

[0034] 5D, the needle 120 and syringe system 140 assembly can be retracted proximally to disengage the needle 120 from the guidewire 130 while leaving a distal portion of the guidewire 130 in place within the vasculature 80. As described in more detail herein, the housing 170 can include a splitter system 180 configured to longitudinally split the needle 120 as the needle 120 is retracted proximally. A portion of the guidewire 130 can pass between the two halves of the needle 120 to allow the needle 120 to disengage the guidewire 130.

[0035] With the needle 120 and syringe system 140 assembly disengaged from the guidewire 130, as shown in FIG. 5E, the catheter 150 may then be advanced over the guidewire 130 into the vasculature. A first portion 154 of the catheter 150, having only a single lumen and defining a relatively small outer diameter, may be advanced along the guidewire 130 into the vasculature and anchor the insertion site. A transition portion 158 may then be urged distally, expanding the insertion site to allow a relatively larger diameter second portion 156, defining two or more lumens, to enter the vasculature 80. Once the catheter 150 is in place, the guidewire 130 may be withdrawn proximally.

[0036] Further details and embodiments of such catheter deployment systems 100 may be found in, for example, U.S. Patent Application No. 10,376,675, U.S. Patent Application Publication No. 2019 / 0255294, U.S. Patent Application Publication No. 2021 / 0069471, U.S. Patent Application Publication No. 2021 / 0085927, U.S. Patent Application Publication No. 2021 / 0113809, U.S. Patent Application Publication No. 2021 / 0113810, U.S. Patent Application Publication No. 2021 / 0121661, U.S. Patent Application Publication No. 2021 / 0121667, U.S. Patent Application Publication No. 2021 / 0228843, U.S. Patent Application Publication No. 2021 / 0228851, U.S. Patent Application Publication No. 2021 / 0228860, U.S. Patent Application Publication No. 2021 / 0228870, U.S. Patent Application Publication No. 2021 / 0228890, U.S. Patent Application Publication No. 2021 / 0228889, U.S. Patent Application Publication No. 2021 / 0228891, U.S. Patent Application Publication No. 2021 / 0228892, U.S. Patent Application Publication No. 2021 / 0228893, U.S. Patent Application Publication No. 2021 / 0228894, U.S. Patent Application Publication No. 2021 / 0228895, U.S. Patent Application Publication No. 2021 / 0228896, U.S. Patent Application Publication No. 2021 / 0228897, U.S. Patent Application Publication No. No. 0322729, U.S. Patent Application Publication No. 2021 / 0330941, U.S. Patent Application Publication No. 2021 / 0330942, U.S. Patent Application Publication No. 2021 / 0361915, U.S. Patent Application Publication No. 2021 / 0402153, U.S. Patent Application Publication No. 2021 / 0402149, U.S. Patent Application Publication No. 2022 / 0001138, U.S. Patent Application No. 17 / 390,682, filed July 30, 2021, and U.S. Provisional Patent Application No. 63 / 229,862, filed August 5, 2021, which are incorporated by reference in their entireties into this application.

[0037] 6A shows a side view of skin incision device 210 with shield 214 positioned in a safety configuration, according to some embodiments. In some embodiments, skin incision device 210 can also be used in conjunction with catheter placement system 100. In some embodiments, skin incision device 210 can be incorporated into catheter placement system 100 to incise the skin as catheter 150 is placed within vasculature 80.

[0038] The skin incision device 210 may be deployed with the needle 120 or may be incorporated into the needle to define a catheter placement device. The skin incision device 210 is configured to slide along the needle 120 and, in some embodiments, to removably couple with the needle hub 126. The skin incision device 210 may be configured to slide proximally and / or distally along the needle 120. The skin incision device 210 includes a blade 230 generally configured to incise / cut the skin adjacent to a catheter insertion site to enlarge the catheter insertion site. In some embodiments, the skin incision device 210 may also include two or more blades 230. The skin incision device 210 (or more specifically, the shield 214) is configured to transition between a safety configuration ( FIG. 6A ) and a use configuration ( FIG. 6B ). In the safety configuration, the blade 230 is stored (or otherwise inaccessible) in the shield 214. In the use configuration, the blade 230 is exposed so that it can be used to score the skin.

[0039] In some embodiments, the skin lancing device 210 may include a frame 212 to which a shield 214 is coupled. In some embodiments, the shield 214 may be hingedly / rotatably coupled to the frame 212 by a hinge 215. In some embodiments, the skin lancing device 210 may also include a blade 230 extending distally from the frame 212. In some embodiments, the shield 214 may be configured to cover the blade 230 to prevent accidental pricking of the blade 230 in a safety configuration. The shield 214 may be configured to transition between a safety configuration and a use configuration, as described in more detail herein. In some embodiments, the blade 230 may have a blade length 232, a blunt edge 240, and a sharp edge 238. In some embodiments, the blunt edge 240 may be positioned adjacent to the needle 120 such that there is substantially no gap between the blunt edge 240 and the needle 120, thereby eliminating the possibility of forming a skin bridge as the blade 230 lancing the skin. In some embodiments, the skin lancing device 210 may be provided separately from the needle 120 and assembled to the needle 120 at the time of use. In other embodiments, the skin lancing device 210 and the needle 120 may be pre-assembled (i.e., coupled). In one embodiment, the frame 212 may be removably coupled to the needle hub 126 such that in the absence of a separation force applied to the skin lancing device 210 by the clinician, the frame 212 is held in position by the needle hub 126. The frame 212 may be coupled to the needle hub 126 with a snap fit, press fit, interference fit, magnetic fit, or the like.

[0040] Blade 230 is fixedly mounted to frame 212 such that blade 230 extends distally from frame 212. The blade includes a sharp edge 238 and a blunt edge 240, with sharp edge 238 facing away from blunt edge 240. Sharp edge 238 is disposed at an angle relative to blunt edge 240, with sharp edge 238 and blunt edge 240 converging to define a sharp tip 239 at the distal end of blade 230.

[0041] In some embodiments, the skin incision device 210 includes a tubular sheath 216 coupled to the frame 212, the tubular sheath 216 extending distally away from the frame 212 along with the needle 120. In such embodiments, the needle 120 is disposed within the lumen 216A of the tubular sheath 216 such that the needle 120 is slidable within the lumen 216A. In some embodiments, the sharpened tip 239 is disposed radially inward of the outer diameter surface 216B of the tubular sheath 216. In some embodiments, the sharpened tip 239 is embedded within the wall 216C of the tubular sheath 216. In some embodiments, the sheath 216 may be omitted.

[0042] FIG. 6B shows a side view of the skin incision device 210 with the shield 214 positioned in a use configuration. The shield 214 is rotated in a direction perpendicular to the needle 120, thereby exposing the blade 230, i.e., allowing the blade 130 to incise the skin. In some embodiments, the shield 214 can be moved at any angle between 0 and 180 degrees relative to the needle 120. With the shield 214 positioned in the use configuration, the frame 212 including the blade 230 can be slid distally along the needle 120 to allow the blade 230 to be inserted into an insertion site and to incise the skin. In use, the frame 212 including the blade 230 can be displaced proximally along the needle 120 away from the insertion site after the skin has been incised. In some embodiments, the frame 212 is configured to reconnect with and be retained by the needle hub 126. The shield 214 can be moved from the use configuration of FIG. 6B back to the safety configuration of FIG. 6A.

[0043] 6A and 6B, in some embodiments, the skin incision device 210 can include a latch 217 operably coupled between the shield 214 and the frame 212. The latch 217 can be configured to lock the shield 214 in a safety configuration to prevent the shield 214 from transitioning from the safety configuration to the use configuration in the absence of an intentional action by the clinician. In some embodiments, the latch 217 includes an actuator 218 configured to release the latch 217 as a result of an intentional action, thereby allowing the shield 214 to transition from the safety configuration to the use configuration.

[0044] 7A and 7B show another embodiment of a skin lancing device 310 that is similar in certain respects to the components of the skin lancing device 210 described in connection with FIGS. 6A and 6B. All of the illustrated embodiments may have similar features. As such, similar features are given similar reference numerals with the leading numeral incremented to "3". For example, a shield is shown in FIGS. 6A and 6B with "214" and a similar shield is shown in FIGS. 7A and 7B with "314". Thus, the relevant disclosure above regarding similarly identified features may not be repeated hereafter. Furthermore, certain features of the skin lancing device 310 and related components shown in FIGS. 6A and 6B may not be shown or identified by reference numerals in the drawings or specifically described in the description set forth below. However, such features may be clearly identical or substantially identical to features described in and / or with respect to other embodiments. Thus, the relevant description of such features applies equally to the features of the skin lancing device 310 of FIGS. 7A and 7B. Any suitable combination of features and variations thereof described with respect to the skin incision device 210 and components shown in Figures 6A and 6B can also be employed with the skin incision device 310 and components of Figures 7A and 7B, and vice versa.

[0045] 7A and 7B show cross-sectional views of a skin incision device 310 transitioning between a safety configuration (FIG. 7A) and a use configuration (FIG. 7B). The skin incision device 310 includes two blades 330 disposed opposite one another relative to the needle 120. The skin incision device 310 further includes a shield 314 that is displaceable (e.g., longitudinally slidable) between the safety configuration and the use configuration. The shield 314 is configured to store the blades 330 (or otherwise render the blades 330 inaccessible) in the safety configuration. In some embodiments, the blades 330 may be configured to fit within or be covered by the shield 314. The shield 314 is configured to be longitudinally displaceable between (i) a distal position corresponding to the safety configuration in which the blades 330 are stored within the shield 314, and (ii) a proximal position corresponding to the use configuration in which the blades 330 extend distally from the shield 314 (i.e., exposed). In some embodiments, the shield 314 may be biased towards the safe configuration, for example, spring biased towards the safe configuration.

[0046] The skin lancing device 310 can include a latch 317 operably coupled between the shield 314 and the frame 312. The latch 317 can be configured to lock the shield 314 in a safety configuration to prevent the shield 314 from transitioning from the safety configuration to the use configuration in the absence of an intentional action by the clinician. In some embodiments, the latch 317 can include an actuator 318 configured to release the latch 317 as a result of an intentional action, thereby allowing the shield 314 to transition from the safety configuration to the use configuration. In some embodiments, the shield 314 can define a shield diameter or width 316. In some embodiments, the actuator 318 of the latch 317 in an undepressed state can extend beyond the shield diameter 316, where the latch 317 prevents proximal displacement of the shield 314 and ensures that the shield 314 remains in the safety configuration. In a depressed state, the actuator 318 can be disposed within the shield diameter 316, thereby allowing proximal displacement of the shield 314 toward the use configuration.

[0047] 8A and 8B, in some embodiments, the blades 330 may be movably coupled to the frame 312 such that the proximal end 334 of each blade 330 is laterally movable relative to the needle 120. For example, as shown in FIG. 8A, each blade 330 may extend laterally away from the needle 120 a first distance 380. To accommodate larger size catheters, the proximal end 334 of the blade 330 may be movable to extend further laterally from the needle 120 to a second distance 382. The second length 382 allows the blade 330 to make a larger incision in the skin during insertion of the needle 120. In some embodiments, the blade 330 may be manually extended from the needle 120 or may be actuated to extend from the needle 120. Advantageously, the proximal end 334 of the blade 330 may be configured to extend to make a larger incision in the skin during insertion of the needle 120, allowing the skin incision device 310 to accommodate catheters of all sizes.

[0048] 9 illustrates a flow chart of an exemplary method 400 of placing a catheter within a patient's vasculature, which may include all or any subset of the following steps, actions, or processes: The method 400 may include accessing a blood vessel using a needle to define an insertion site for the catheter (Block 410).

[0049] The method 400 may further include transitioning a shield of the skin-incision device coupled with the needle from a safety configuration to a use configuration to expose a blade of the skin-incision device (Block 420). In some embodiments of the method, transitioning the shield includes rotating the shield. In some embodiments of the method, transitioning the shield from the safety configuration to the use configuration includes slidably displacing the shield from a distal position to a proximal position. In some embodiments of the method 400, transitioning the shield from the safety configuration to the use configuration includes contacting the skin with the shield.

[0050] The method 400 may further include releasing a latch operably coupled between the shield and the frame (block 430) to allow the shield to transition from the secure configuration to the use configuration.

[0051] The method 400 may further include sliding the skin incision device distally along the needle toward the insertion site (block 440). In some embodiments of the method 400, a frame of the skin incision device may be decoupled from a needle hub of the needle prior to sliding the skin incision device distally. In some embodiments of the method 400, sliding the skin incision device distally may include displacing the skin incision device distally such that the skin exerts a proximal force on the shield to displace the shield from a distal position toward a proximal position.

[0052] Method 400 may further include cutting the skin with a blade to enlarge the insertion site (block 450). In some embodiments of method 400, cutting the skin includes sliding a skin cutting device distally along the needle such that the blade extends into the insertion site.

[0053] The method 400 may further include placing the catheter within the vasculature (Block 460). The method 400 may further include transitioning the shield from the use configuration to the safety configuration to retract the blade (Block 470).

[0054] Some specific embodiments are disclosed herein, and although the specific embodiments are disclosed in some detail, the specific embodiments are not intended to limit the scope of the concept provided herein. Additional adaptations and / or modifications may be apparent to those skilled in the art, and the broader aspects also encompass these adaptations and / or modifications. Thus, one may deviate from the specific embodiments disclosed herein without departing from the scope of the concept provided herein.

Claims

1. A catheter placement device, comprising: a needle configured to establish an insertion site for a vascular catheter, the needle defining a needle lumen extending between a distal end and a needle hub at a proximal end; a skin lancing device slidably coupled to the needle, a blade configured to incise the skin adjacent the insertion site to enlarge the insertion site; a shield, a safety arrangement in which the blade is retracted by the shield; a shield that is transitionable between a use configuration in which the blade is exposed to cut the skin; and a skin incision device comprising: A catheter placement device comprising:

2. The device of claim 1 , wherein the skin lancing device includes a frame coupled with the blade and the shield.

3. 3. The device of claim 2, wherein the frame is coupled to the needle hub such that the frame is held in position by the needle hub in the absence of a separation force applied to the skin lancing device by a clinician.

4. 4. The device of claim 2 or 3, wherein the shield is rotatably coupled to the frame such that the shield is rotatable between the safety configuration and the use configuration.

5. 4. The device of claim 2 or 3, wherein the shield is slidably coupled to the frame such that the shield is displaceable between the safety configuration and the use configuration.

6. The shield is a distal position corresponding to the safety configuration; and and a proximal position corresponding to the use configuration.

7. The device of any one of claims 1 to 3, wherein the shield is biased towards the safety configuration.

8. the skin lancing device includes a latch operably coupled between the shield and the frame; 4. The device of claim 2 or 3, wherein the latch is configured to prevent the shield from transitioning from the safety configuration to the use configuration in the absence of intentional action by a clinician.

9. 9. The device of claim 8, wherein the latch includes an actuator configured to release the latch as a result of intentional action by a clinician, thereby allowing the shield to transition from the safety configuration to the use configuration.

10. 4. The device of claim 2 or 3, wherein the blade is fixedly attached to the frame so as to extend distally away from the frame.

11. the blade has a sharp edge and a blunt edge; the sharp edge faces away from the blunt edge; The device of any one of claims 1 to 3, wherein the sharp edge is disposed at an angle to the blunt edge.

12. The device of claim 11 , wherein the sharp edge and the blunt edge converge to define a sharp point at the distal end of the blade.

13. The blade is with the blunt edge facing the needle, the sharp edge faces radially away from the needle; and 13. The device of claim 12, wherein the sharpened tip is fixedly attached to the frame so as to be positioned immediately adjacent the needle.

14. the skin lancing device includes a tubular sheath coupled to the frame so as to extend distally away from the frame along the needle; The device of claim 2 or 3, wherein the needle is disposed within the lumen of the tubular sheath.

15. The device of claim 14 , wherein the sharp tip is disposed radially inward of an outer diameter surface of the tubular sheath.

16. The device of claim 14 , wherein the sharp tip is embedded within the wall of the tubular sheath.

17. The device of claim 2 or 3, wherein the skin lancing device includes a second blade, the second blade being fixedly coupled to the frame such that the second blade is positioned opposite the blade.

18. The shield is storing the second blade in the safety configuration; The device of claim 17 , wherein the second blade is exposed in the use configuration.

Images